Growth Metrics

Palvella Therapeutics (PVLA) EBT (QoQ) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Palvella Therapeutics 1.47 Bn 1.21 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -154.25%
Dec 31, 2025 356.19%
Sep 30, 2025 -19.79%
Jun 30, 2025 -15.71%
Mar 31, 2025 -160.71%
Dec 31, 2024 299.01%
Sep 30, 2024 -62.39%
Jun 30, 2024 -64.51%
Mar 31, 2024 -118.95%
Dec 31, 2023 218.90%
Sep 30, 2023 -540.97%
Jun 30, 2023 116.85%
Sep 30, 2022 2.22%
Jun 30, 2022 -63.51%
Mar 31, 2022 32.21%
Dec 31, 2021 42.10%
Sep 30, 2021 -13.43%
Jun 30, 2021 -231.45%
Mar 31, 2021 59.24%
Dec 31, 2020 4.18%
Sep 30, 2020 -185.99%
Jun 30, 2020 -27.96%
Mar 31, 2020 -358.75%
Dec 31, 2019 70.25%
Sep 30, 2019 77.96%
Jun 30, 2019 -13.63%
Mar 31, 2019 12.65%
Dec 31, 2018 -92.52%
Sep 30, 2018 -1,652.99%
Jun 30, 2018 95.97%
Mar 31, 2018 -214.13%
Dec 31, 2017 210.44%
Sep 30, 2017 25.43%
Jun 30, 2017 -15.97%
Mar 31, 2017 -24.97%
Dec 31, 2016 -3.23%
Sep 30, 2016 -5.32%
Jun 30, 2016 -41.39%
Mar 31, 2016 -51.96%
Dec 31, 2015 29.46%
Sep 30, 2015 -9.97%
Jun 30, 2015 4.72%
Sep 30, 2014 29.83%
Jun 30, 2014 -269.48%
Mar 31, 2014 -35,383.30%
Dec 31, 2013 61.85%
Sep 30, 2013 -2,002.92%